Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis
- PMID: 16081966
- PMCID: PMC1233913
- DOI: 10.1128/JCM.43.8.4163-4167.2005
Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis
Abstract
Non-beta-lactam inhibitor-based methods were evaluated for detecting plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. Using CLSI methodology and disks containing cefotetan alone and in combination with 400 mug of boronic acid, 9 of 10 positive control strains and 54 of 55 AmpC-PCR-positive clinical isolates were detected. Importantly 71% and 40% of these clinical isolates were susceptible by routine testing to ceftriaxone and ceftazidime, respectively. Boronic acid disks also enhanced detection of expanded-spectrum beta-lactamases in AmpC producers.
Figures


Similar articles
-
Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.J Clin Pathol. 2008 May;61(5):642-4. doi: 10.1136/jcp.2007.053470. Epub 2007 Dec 5. J Clin Pathol. 2008. PMID: 18057079
-
Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.Diagn Microbiol Infect Dis. 2007 Mar;57(3):315-8. doi: 10.1016/j.diagmicrobio.2006.08.023. Epub 2006 Dec 15. Diagn Microbiol Infect Dis. 2007. PMID: 17174510
-
Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.J Clin Microbiol. 2007 Apr;45(4):1180-4. doi: 10.1128/JCM.02322-06. Epub 2007 Feb 14. J Clin Microbiol. 2007. PMID: 17301276 Free PMC article.
-
Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.Clin Infect Dis. 2006 Apr 15;42 Suppl 4:S153-63. doi: 10.1086/500662. Clin Infect Dis. 2006. PMID: 16544266 Review.
-
Detection of plasmid-mediated class C beta-lactamases.Int J Infect Dis. 2007 May;11(3):191-7. doi: 10.1016/j.ijid.2006.07.008. Epub 2007 Mar 6. Int J Infect Dis. 2007. PMID: 17339123 Review.
Cited by
-
Evaluation of four phenotypic methods to detect plasmid-mediated AmpC β-lactamases in clinical isolates.Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2037-43. doi: 10.1007/s10096-011-1537-y. Epub 2012 Jan 26. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22278294
-
Carriage of Extended-Spectrum-β-Lactamase- and AmpC-β-Lactamase-Producing Enterobacteriaceae (ESBL-PE) in Healthy Community and Outpatient Department (OPD) Patients in Nepal.Can J Infect Dis Med Microbiol. 2020 Feb 11;2020:5154217. doi: 10.1155/2020/5154217. eCollection 2020. Can J Infect Dis Med Microbiol. 2020. PMID: 32104519 Free PMC article.
-
Redefining extended-spectrum beta-lactamases: balancing science and clinical need.J Antimicrob Chemother. 2009 Jan;63(1):1-4. doi: 10.1093/jac/dkn444. Epub 2008 Oct 28. J Antimicrob Chemother. 2009. PMID: 18957393 Free PMC article.
-
Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin.J Lab Physicians. 2013 Jul;5(2):90-3. doi: 10.4103/0974-2727.119849. J Lab Physicians. 2013. PMID: 24701100 Free PMC article.
-
Genotypic Identification of AmpC β-Lactamases Production in Gram-Negative Bacilli Isolates.Jundishapur J Microbiol. 2014 Jan;7(1):e8556. doi: 10.5812/jjm.8556. Epub 2014 Jan 1. Jundishapur J Microbiol. 2014. PMID: 25147649 Free PMC article.
References
-
- Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569. - PMC - PubMed
-
- Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 45:783-788. - PubMed
-
- Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne. Pa.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous